D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 89 Citations 28,206 585 World Ranking 6298 National Ranking 294

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Magnetic resonance imaging

Friedemann Paul mainly focuses on Multiple sclerosis, Pathology, Neuromyelitis optica, Optic neuritis and Immunology. His Multiple sclerosis research is multidisciplinary, incorporating elements of Internal medicine and Neurology, Neuroscience. His Pathology research is multidisciplinary, incorporating perspectives in Magnetic resonance imaging, Clinically isolated syndrome, Magnetic resonance elastography and Ganglion.

His Neuromyelitis optica study combines topics from a wide range of disciplines, such as Dermatology, Transverse myelitis, Azathioprine, Rituximab and Optic nerve. His work deals with themes such as Ophthalmology, Retinal, Nerve fiber layer, Autoantibody and Myelitis, which intersect with Optic neuritis. His research in Immunology intersects with topics in Aquaporin 4, Epidemiology and Cerebrospinal fluid.

His most cited work include:

  • Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients (425 citations)
  • MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome (400 citations)
  • Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS) (366 citations)

What are the main themes of his work throughout his whole career to date?

Friedemann Paul mainly investigates Multiple sclerosis, Pathology, Neuromyelitis optica, Optic neuritis and Internal medicine. The Multiple sclerosis study combines topics in areas such as Magnetic resonance imaging and Disease. Friedemann Paul interconnects White matter, Inflammation, Central nervous system, Neurology and In vivo in the investigation of issues within Pathology.

Friedemann Paul combines subjects such as Dermatology, Aquaporin 4, Myelitis, Spectrum disorder and Pediatrics with his study of Neuromyelitis optica. His Optic neuritis research integrates issues from Ophthalmology and Optic nerve. The study incorporates disciplines such as Gastroenterology, Endocrinology and Cardiology in addition to Internal medicine.

He most often published in these fields:

  • Multiple sclerosis (64.85%)
  • Pathology (29.02%)
  • Neuromyelitis optica (26.98%)

What were the highlights of his more recent work (between 2019-2021)?

  • Multiple sclerosis (64.85%)
  • Neuromyelitis optica (26.98%)
  • Internal medicine (20.44%)

In recent papers he was focusing on the following fields of study:

Friedemann Paul focuses on Multiple sclerosis, Neuromyelitis optica, Internal medicine, Disease and Optic neuritis. His Multiple sclerosis research includes themes of Magnetic resonance imaging and Cohort, Pathology. His Neuromyelitis optica research is multidisciplinary, incorporating elements of Dermatology, Central nervous system, Myelitis, Myelin oligodendrocyte glycoprotein and Spectrum disorder.

His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Lesion and Expanded Disability Status Scale. His studies deal with areas such as Neuropathic pain, Pediatrics and Depression as well as Disease. His Optic neuritis research includes elements of Ophthalmology, Retinal and Audiology.

Between 2019 and 2021, his most popular works were:

  • Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide. (39 citations)
  • Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients (22 citations)
  • Treatment of MOG antibody associated disorders: results of an international survey (16 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Magnetic resonance imaging

His primary scientific interests are in Multiple sclerosis, Internal medicine, Optic neuritis, Neuromyelitis optica and Disease. The concepts of his Multiple sclerosis study are interwoven with issues in Clinical trial, Cohort and Pathology. Friedemann Paul has researched Pathology in several fields, including White matter, Myelin, Oligodendrocyte and Putamen.

His Internal medicine study incorporates themes from Gastroenterology and Cytometry. The various areas that Friedemann Paul examines in his Optic neuritis study include Ophthalmology, Retinal, Optical coherence tomography, Optic nerve and Fingolimod. His Neuromyelitis optica study combines topics in areas such as Dermatology, Myelin oligodendrocyte glycoprotein, Myelitis and Encephalomyelitis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

Sven Jarius;Klemens Ruprecht;Ingo Kleiter;Nadja Borisow.
Journal of Neuroinflammation (2016)

612 Citations

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

Sven Jarius;Klemens Ruprecht;Brigitte Wildemann;Tania Kuempfel.
Journal of Neuroinflammation (2012)

576 Citations

Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)

Corinna Trebst;Sven Jarius;Achim Berthele;Friedemann Paul;Friedemann Paul.
Journal of Neurology (2014)

461 Citations

MRI characteristics of neuromyelitis optica spectrum disorder An international update

Ho Jin Kim;Friedemann Paul;Marco A. Lana-Peixoto;Silvia Tenembaum.
Neurology (2015)

410 Citations

A blood based 12-miRNA signature of Alzheimer disease patients

Petra Leidinger;Christina Backes;Stephanie Deutscher;Katja Schmitt.
Genome Biology (2013)

391 Citations

No Cerebrocervical Venous Congestion in Patients with Multiple Sclerosis

Florian Doepp;Friedemann Paul;José M. Valdueza;Klaus Schmierer;Klaus Schmierer.
Annals of Neurology (2010)

373 Citations

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

Sven Jarius;Klemens Ruprecht;Ingo Kleiter;Nadja Borisow.
Journal of Neuroinflammation (2016)

353 Citations

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.

Sven Jarius;Friedemann Paul;Diego Franciotta;Patrick Waters.
Nature Reviews Neurology (2008)

345 Citations

MOG encephalomyelitis: International recommendations on diagnosis and antibody testing

S. Jarius;F. Paul;F. Paul;O. Aktas;N. Asgari.
Journal of Neuroinflammation (2018)

307 Citations

Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica

Ingo Kleiter;Kerstin Hellwig;Achim Berthele;Tania Kümpfel.
JAMA Neurology (2012)

279 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Friedemann Paul

Axel Petzold

Axel Petzold

University College London

Publications: 82

Sven Jarius

Sven Jarius

Heidelberg University

Publications: 76

Kazuo Fujihara

Kazuo Fujihara

Fukushima Medical University

Publications: 71

Patrick Waters

Patrick Waters

University of Oxford

Publications: 66

Brigitte Wildemann

Brigitte Wildemann

University Hospital Heidelberg

Publications: 65

Frederik Barkhof

Frederik Barkhof

University College London

Publications: 63

Sean J. Pittock

Sean J. Pittock

Mayo Clinic

Publications: 61

Andreas Keller

Andreas Keller

Saarland University

Publications: 60

Markus Reindl

Markus Reindl

Innsbruck Medical University

Publications: 57

Jacqueline Palace

Jacqueline Palace

University of Oxford

Publications: 53

Peter A. Calabresi

Peter A. Calabresi

Johns Hopkins University School of Medicine

Publications: 53

Robert Zivadinov

Robert Zivadinov

University at Buffalo, State University of New York

Publications: 53

Bianca Weinstock-Guttman

Bianca Weinstock-Guttman

University at Buffalo, State University of New York

Publications: 52

Josep Dalmau

Josep Dalmau

University of Barcelona

Publications: 51

Hans-Peter Hartung

Hans-Peter Hartung

Heinrich Heine University Düsseldorf

Publications: 50

Massimo Filippi

Massimo Filippi

Vita-Salute San Raffaele University

Publications: 48

Trending Scientists

Nigel Shadbolt

Nigel Shadbolt

University of Oxford

Paul Furgale

Paul Furgale

ETH Zurich

Edward M. Riseman

Edward M. Riseman

University of Massachusetts Amherst

Hector J. Levesque

Hector J. Levesque

University of Toronto

Arvind Raman

Arvind Raman

Purdue University West Lafayette

Nathan van de Wouw

Nathan van de Wouw

Eindhoven University of Technology

William A. Hopkins

William A. Hopkins

Virginia Tech

James D. Young

James D. Young

University of Alberta

Dennis A. Senne

Dennis A. Senne

Animal and Plant Health Inspection Service

Nadim J. Ajami

Nadim J. Ajami

The University of Texas MD Anderson Cancer Center

Shigeyuki Hamada

Shigeyuki Hamada

Osaka University

Dirk Klaeschen

Dirk Klaeschen

GEOMAR Helmholtz Centre for Ocean Research Kiel

Xavier Crosta

Xavier Crosta

University of Bordeaux

Henrik Skov

Henrik Skov

Aarhus University

Laurie A. Miller

Laurie A. Miller

Royal Prince Alfred Hospital

Douglas L. Mann

Douglas L. Mann

Washington University in St. Louis

Something went wrong. Please try again later.